Tender detail
Conclusion of a non-exclusive rebate agreement under Section 130a(8) SGB V for the active substance Daridorexant, ATC N05CJ03, for the period 01/06/2026–31/05/2028
Summary
The tender concerns a non-exclusive rebate agreement for medicines containing the active substance daridorexant for the period 01/06/2026–31/05/2028. It is an open accession model: interested pharmaceutical companies may join the contract if they submit the required documents on time by email. The bidder must note that the exact qualification and compliance requirements are partly only in the tender documents and must be checked there.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.